Atenolol: Difference between revisions
(→Common) |
|||
| Line 35: | Line 35: | ||
===Common=== | ===Common=== | ||
*bradycardia | |||
*hypotension | |||
*fatigue | |||
*dizziness | |||
*cold extremities | |||
*depression | |||
*dyspnea | |||
*hypotension, orthostatic | |||
*leg pain | |||
*bronchospasm | |||
*lightheadedness | |||
*lethargy | |||
*diarrhea | |||
*nausea | |||
*vertigo | |||
*drowsiness | |||
==Pharmacology== | ==Pharmacology== | ||
Revision as of 22:25, 26 June 2015
General
- Type: Beta blocker
- Dosage Forms: PO
- Common Trade Names: Tenormin
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- CHF
- bradycardia, severe
- heart block
- angina exacerbation if abrupt D/C
- MI if abrupt D/C
- ventricular arrhythmia during tx and if abrupt D/C
- Raynaud phenomenon
- bronchospasm
- hypersensitivity rxn
- lupus erythematosus
Common
- bradycardia
- hypotension
- fatigue
- dizziness
- cold extremities
- depression
- dyspnea
- hypotension, orthostatic
- leg pain
- bronchospasm
- lightheadedness
- lethargy
- diarrhea
- nausea
- vertigo
- drowsiness
Pharmacology
- Half-life: 6-7h
- Metabolism: CYP450
- Excretion: urine 40-50%, feces 50%
- Mechanism of Action: selectively antagonizes beta-1 adrenergic receptors